The success of Viagra initially sparked a period of growth for pharma, but recent developments present a murky outlook for those considering a stake. Lower-cost versions are reducing revenue, and continued legal https://mathebjcb601991.bloginder.com/41806304/sildenafil-and-pharma-a-precarious-investment